Facebook
Twitter
Home 
How Blumble Works 
Search Algorithm 
Your Privacy 
About 
Blog
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it was named to the JUST 100 list of America's most just companies by JUST Capital and its media partner CNBC.
YAHOO!Finance - Jan 11, 2022
Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic buyouts.
Entrepreneur - Jan 11, 2022
Becton, Dickinson and Company BDX, popularly known as BD, recently received the 510(k) clearance from the FDA for the BD Kiestra IdentifA system. The system has been developed to automate the preparation of microbiology bacterial identification testing.
Nasdaq - Jan 10, 2022
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.
Benzinga.com - Jan 11, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD Kiestra™ IdentifA system,
YAHOO!Finance - Jan 07, 2022
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its first quarter of fiscal year 2022 on Thursday, Feb. 3, 2022. A news release will be issued at approximately 6 a.
Business Insider - Jan 05, 2022
As we hurtle into 2022, I’d like you to read this article and reflect on some things that you are not going to do for the year ahead. An anti-New Year’s Resolution, if you like? I’d like you to pause,
LinkedIn - Jan 09, 2022
BD (NYSE:BDX) announced yesterday that it will collaborate with Pfizer and Wellcome to advance antimicrobial stewardship practices.
Medical Design and Outsourcing - Jan 12, 2022
BD Commemorates 10th Anniversary of its Initiative FITTER - Forum for Injection Technique & Therapy Expert Recommendations: 11/01/2022: BD Commemorate
PTI - Jan 11, 2022
Becton Dickinson has received 510 (k) clearance from the FDA for its BD Kiestra IdentifA system, which is designed to automate the preparation of bacterial samples for testing. The system uses the company’s Synapsys informatics to help lab technicians select bacterial colonies from a digital plate image.
FDAnews - Jan 12, 2022
Forum for Injection Technique & Therapy Expert Recommendations, is an initiative on educating people with diabetes on safe injection practices and runs several educational and awareness programs
expresshealthcare - Jan 12, 2022
Norton safe Web